OTCMKTS:CYAN Cyanotech Q2 2025 Earnings Report $0.31 -0.04 (-10.71%) As of 10:30 AM Eastern ProfileEarnings History Cyanotech EPS ResultsActual EPS-$0.16Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ACyanotech Revenue ResultsActual Revenue$5.85 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ACyanotech Announcement DetailsQuarterQ2 2025Date11/12/2024TimeBefore Market OpensConference Call DateTuesday, November 12, 2024Conference Call Time9:30AM ETConference Call ResourcesEarnings HistoryCompany Profile Cyanotech Earnings HeadlinesCyanotech (OTCMKTS:CYAN) Shares Cross Below 200-Day Moving Average - Here's What HappenedOctober 1 at 3:01 AM | americanbankingnews.comCyanotech (OTCMKTS:CYAN) Stock Passes Above 50 Day Moving Average - What's Next?September 22, 2026 | americanbankingnews.comElon will prove them wrong againElon Musk's critics said self-driving cars were a pipe dream. Today, Tesla robotaxis carry passengers with no driver in major U.S. cities. Veteran tech investor James Altucher says Musk is applying the same playbook to a new project he calls his infinite money glitch, expected to launch October 21. Altucher, who has tracked tech breakthroughs for nearly four decades, calls this the biggest one he has ever covered.October 2 at 1:00 AM | Paradigm Press (Ad)Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2024May 20, 2026 | finanznachrichten.deSpirulina Extract Market | 6.0% CAGR | Asia Pacific, USA, Europe Lead | DIC Corp, Cyanotech, Parry Nutraceuticals Drive Clean-Label RevolutionApril 8, 2026 | finance.yahoo.comCyanotech Corp.February 13, 2026 | marketwatch.comSee More Cyanotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cyanotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cyanotech and other key companies, straight to your email. Email Address About CyanotechCyanotech (OTCMKTS:CYAN) is a biotechnology company that cultivates and processes microalgae for use in nutritional supplements, functional foods, and natural ingredients. The company operates from the Kona coast of Hawaii, where its production facilities use open-pond cultivation to grow algae in a controlled environment. Its principal products include Hawaiian Spirulina Pacifica, a spirulina-based nutritional supplement, and BioAstin Hawaiian Astaxanthin, a natural astaxanthin product derived from the microalga Haematococcus pluvialis. Cyanotech has also developed other algae-based ingredients and formulations for consumer and commercial applications. Founded in 1969, Cyanotech has focused on commercial microalgae production and the development of algae-derived health and wellness products. Its products have been marketed through retail, direct-to-consumer, and commercial distribution channels in the United States and internationally.View Cyanotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes NextTarget's Holiday Blitz: Slashing Prices to Capture Market ShareCleared for Takeoff: AAR Corp. Expands Its Aerospace Aftermarket Reach Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
